Source: BioSpace

IBEX: Ibex Medical Analytics Enters Collaboration with AstraZeneca and Daiichi Sankyo to Develop AI-based HER2 Scoring Product

Ibex Medical Analytics today announced an agreement with AstraZeneca and Daiichi Sankyo, for the development, clinical validation and early adoption of an AI-powered product to aid pathologists with an accurate and reproducible assessment of HER2 immunohistochemistry (IHC) scoring in breast cancer patients.

Read full article »
Est. Annual Revenue
Est. Employees
Joseph Mossel's photo - Co-Founder & CEO of IBEX

Co-Founder & CEO

Joseph Mossel

CEO Approval Rating


Read more